Former Woodford dud sees fortunes climb on controversial approval of Alzheimer’s drug
Prothena’s share price has spiked 484% this year
- News
-
- Analysis
-
- Investments
-
-
-
Top story
-
-
-
- Video
-
Equities
-
-
Will the UK see its own Spac boom?
US popularity is soaring, and they are heading to UK shores, but historic red flags are making investors nervous
-
UK equities edge back into favour but not enough to unseat global funds
Investors more optimistic ahead of third quarter earnings
-
Square Mile pulls Royal London UK Equity Income rating after weighing up Martin Cholwill successor
While it reinstates recommended rating for Janus Henderson’s £1.1bn UK property fund
-
China looks set to loosen the purse strings again
Following the disappointing string of data in July, the policy mix is turning more dovish
-
UK funds break outflows streak as investors splash £4.8bn in July
July retail flows were nearly three times higher than a year ago
-
High active share key to beating passives as value rally stalls
Just a quarter of active funds outperformed their passive counterparts in Q2
-
Blackrock moves overweight European equities despite industry’s downbeat economic sentiment
Fund buyers meanwhile seem split on the prospects for Europe’s equity market
-
To infinity and beyond: Is space tech the next big investment opportunity?
Commercial space travel fuels interest in nascent sector but fund buyers urge caution
-
Adrian Gosden lands Elite rating from Fundcalibre after passing three-year milestone
Seven funds bag top rating, while two newcomers awarded Elite Radar badges
-
Will tech rally run out of steam as hybrid working becomes the norm?
The ‘easy money’ has already been made but shift away from five-day office era opens up opportunities for new digital disruptors
-
Execs at Woodford darling Oxford Nanopore set for bumper £160m payday
DNA sequencing unicorn reported a £73m pre-tax loss in 2020 despite revenue boost from government contracts for Covid tests